Use of GLP-1 receptor agonists to treat substance and alcohol use disorders is promising, but premature, say researchers
Semaglutide, a glucagon-like peptide-1 receptor agonist (GLP-1RA) originally formulated to treat diabetes, has gained traction as the latest and greatest weight loss drug. Among the hype, anecdotal observations from patients ...
Dec 5, 2023
0
11